MedPath
NMPA Approval

Vortioxetine Hydrobromide Tablets

国药准字H20253149

January 14, 2025

Drug Information

氢溴酸伏硫西汀片

片剂

10mg(以C₁₈H₂₂N₂S计)

化学药品

January 14, 2025

Company Information

Applicant Company

深泽县工业园区(西环路16号)

Manufacturing Company

深泽县工业园区(西环路16号)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氢溴酸伏硫西汀片 - NMPA 批准文号 | MedPath